Pulmonology (1 POC)

個数:

Pulmonology (1 POC)

  • 提携先の海外書籍取次会社に在庫がございます。通常2週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 330 p.
  • 言語 ENG,ENG
  • 商品コード 9781591032632
  • DDC分類 616

Table of Contents

    1 Anatomy and Physiology                       9  (21)
1.1 Anatomy 9 (14)
1.1.1 Upper airways 9 (2)
1.1.2 Lower airways 11 (3)
1.1.3 Lungs 14 (3)
1.1.4 Pleura 17 (1)
1.1.5 Thorax 17 (1)
1.1.6 Respiratory muscles 18 (1)
1.1.7 Lung defenses 19 (1)
1.1.8 Lung innervation 20 (1)
1.1.9 Lung circulation 20 (3)
1.2 Physiology 23 (7)
1.2.1 Ventilation 23 (1)
1.2.2 Ventilation-perfusion (V/Q) 23 (1)
relationship
1.2.3 Diffusion of gases 24 (2)
1.2.4 Mechanics of respiration 26 (2)
1.2.5 Control of respiration 28 (2)
2 Assessment and Monitoring 30 (51)
2.1 History and Physical Examination 30 (7)
2.1.1 Vital signs 30 (1)
2.1.2 Respiratory breathing patterns 31 (1)
2.1.3 Chest shape 31 (1)
2.1.4 Use of accessory muscles 32 (1)
2.1.5 Cyanosis 32 (1)
2.1.6 Finger clubbing 32 (1)
2.1.7 Capillary refill 32 (1)
2.1.8 Peripheral edema 33 (1)
2.1.9 Jugular venous distention (JVD) 33 (1)
2.1.10 Percussion of the chest 33 (1)
2.1.11 Auscultation 33 (2)
2.1.12 Sputum examination 35 (1)
2.1.13 Symptoms 35 (2)
2.2 Arterial Blood Gases 37 (13)
2.2.1 Assessing oxygenation 37 (7)
2.2.2 Assessing ventilation 44 (3)
2.2.3 Noninvasive monitoring of 47 (3)
bloodgases
2.3 Thoracic imaging 50 (9)
2.3.1 Chest X-ray 50 (6)
2.3.2 Other imaging techniques of the 56 (3)
thorax
2.4 Pulmonary Function Tests (PFT) 59 (13)
2.4.1 Indications 59 (1)
2.4.2 Contraindications 60 (1)
2.4.3 Spirometry 60 (5)
2.4.4 Diffusion capacity (DLCO) 65 (3)
2.4.5 Summarizing pulmonary 68 (1)
functiontests
2.4.6 Bronchial provocation 69 (3)
2.5 Cardiopulmonary Exercise Testing 72 (6)
(CPET)
2.5.1 Simple tests of exercise capacity 72 (1)
2.5.2 Progressive exercise testing 73 (5)
2.6 Bronchoscopy 78 (3)
2.6.1 Basic bronchoscopic techniques 78 (2)
2.6.2 Advanced bronchoscopic techniques 80 (1)
3 Obstructive Lung Diseases 81 (48)
3.1 Asthma 81 (20)
3.1.1 Definition 81 (1)
3.1.2 Statistics 81 (1)
3.1.3 Etiology 81 (1)
3.1.4 Pathology 82 (1)
3.1.5 Clinical features 83 (1)
3.1.6 Diagnosis 83 (1)
3.1.7 Monitoring 84 (1)
3.1.8 Differential diagnosis 84 (1)
3.1.9 Classification 85 (1)
3.1.10 Managing chronic asthma 86 (3)
3.1.11 Pharmacologic treatment 89 (4)
3.1.12 Difficult-to-treat asthma 93 (1)
3.1.13 Asthma exacerbation 93 (8)
3.2 COPD (Chronic Obstructive Pulmonary 101(24)
Disease)
3.2.1 Definition 101(1)
3.2.2 Statistics 102(1)
3.2.3 Etiology 102(1)
3.2.4 Pathophysiology 103(1)
3.2.5 Clinical manifestations 103(1)
3.2.6 Diagnosis 104(2)
3.2.7 Differential diagnosis 106(2)
3.2.6 Classification 108(1)
3.2.9 Reduction of risk factors 109(1)
3.2.10 Managing stable COPD 110(7)
3.2.11 Managing exacerbations 117(8)
3.3 Bronchiectasis 125(4)
3.3.1 Definition 125(1)
3.3.2 Classification 125(1)
3.3.3 Etiology 125(1)
3.3.4 Pathophysiology 126(1)
3.3.5 Clinical manifestations 126(1)
3.3.6 Complications 127(1)
3.3.7 Diagnosis 127(1)
3.3.8 Recommended evaluation 127(1)
3.3.9 Therapy 127(2)
4 Pulmonary Infections 129(47)
4.1 Pneumonia 129(38)
4.1.1 Definition 129(1)
4.1.2 Community-acquired pneumonia (CAP) 129(10)
4.1.3 Hospital-acquired pneumonia (HAP) 139(8)
4.1.4 Aspiration pneumonia 147(2)
4.1.5 Pneumocystis Jiroveci pneumonia 149(1)
(PJP)
4.1.6 Fungal pneumonia 150(17)
4.2 Lung Abscess 167(1)
4.2.1 Definition 167(1)
4.2.2 Causes 167(1)
4.2.3 Clinical features 167(1)
4.2.4 Diagnosis 167(1)
4.2.5 Therapy 167(1)
4.3 Tuberculosis (TB) 168(4)
4.3.1 Epidemiology 168(1)
4.3.2 Etiology 168(1)
4.3.3 Clinical features 168(1)
4.3.4 Diagnosis 169(1)
4.3.5 Therapy 170(2)
4.4 Nontubecculous Mycobacterial Diseases 172(4)
4.4.1 Clinical features 172(1)
4.4.2 Diagnosis 172(1)
4.4.3 Therapy 173(3)
5 Interstitial Lung Diseases (ILD) 176(15)
5.1 Idiopathic Interstitial Pneumonias 176(3)
5.1.1 Idiopathic pulmonary fibrosis 176(1)
(IPF)
5.1.2 Non specific interstitial 176(1)
pneumonitis (NSIP)
5.1.3 Cryptogenic organizing pneumonia 177(1)
(COP)
5.1.4 Acute interstitial pneumonia (AIP) 177(1)
5.1.5 Desquamative interstitial 178(1)
pneumonia (DIP)
5.1.6 Respiratory bronchiolitis (RB) 178(1)
5.1.7 Lymphocytic interstitial 179(1)
pneumonia (LIP)
5.2 Pneumoconioses 179(3)
5.2.1 Asbestosis 179(1)
5.2.2 Berylliosis 180(1)
5.2.3 Byssinosis 180(1)
5.2.4 Coal worker's pneumoconiosis, 180(1)
(CWP)
5.2.5 Silicosis 181(1)
5.3 Sarcoidosis 182(2)
5.3.1 Description 182(1)
5.3.2 Incidence 182(1)
5.3.3 Clinical features 182(1)
5.3.4 Diagnosis 183(1)
5.3.5 Therapy 183(1)
5.4 Hypersensitivity Pneumonitis (HP) 184(2)
5.4.1 Description 184(1)
5.4.2 Etiology 184(1)
5.4.3 Clinical features and diagnosis 184(1)
5.4.4 Differential diagnosis 185(1)
5.4.5 Therapy 186(1)
5.5 Pulmonary Lymphangioleiomyomatosis 186(1)
5.6 Eosinophilic Lung Disease 187(1)
5.6.1 Idiopathic eosinophilic lung 187(1)
diseases
5.7 Radiation-Induced Lung Injury 188(1)
5.7.1 Three patterns 188(1)
5.7.2 Increased risk 189(1)
5.7.3 Therapy 189(1)
5.8 Pulmonary Vasculitis 189(2)
5.8.1 Wegener granuiomatosis 189(1)
5.8.2 Churg-Strauss syndtome 190(1)
5.8.3 Microscopic polyangiitis 190(1)
5.8.4 Therapy 190(1)
6 Pulmonary Vascular Diseases 191(24)
6.1 Pulmonary Edema 191(5)
6.1.1 Definition 191(1)
6.1.2 Etiology 191(1)
6.1.3 Clinical Features 191(1)
6.1.4 Diagnosis 192(2)
6.1.5 Therapy 194(2)
6.2 Pulmonary Embolism (PE) 196(6)
6.2.1 Definition 196(1)
6.2.2 Incidence 196(1)
6.2.3 Etiology 196(1)
6.2.4 Clinical features 197(1)
6.2.5 Differential diagnosis 197(1)
6.2.6 Diagnosis 197(2)
6.2.7 Therapy 199(3)
6.3 Pulmonary Hypertension (PH) 202(8)
6.3.1 Definition 202(1)
6.3.2 Etiology 202(1)
6.3.3 Clinical features 203(1)
6.3.4 Diagnosis/Evaluation 203(3)
6.3.5 WHO functional classification 206(1)
6.3.6 Therapy 206(3)
6.3.7 Prognosis 209(1)
6.4 Cor Pulmonale 210(1)
6.4.1 Description 210(1)
6.4.2 Important causes 210(1)
6.4.3 Clinical features 210(1)
6.4.4 Diagnosis 210(1)
6.4.5 Therapy 211(1)
6.5 Arteriovenous Malformations (AVMs) 211(2)
6.5.1 Description 211(1)
6.5.2 Important causes 211(1)
6.5.3 Clinical features 212(1)
6.5.4 Diagnosis 212(1)
6.5.5 Therapy 213(1)
6.5.6 Special considerations 213(1)
6.6 Pulmonary Veno-Occlusive Disease 213(2)
(PVOD)
6.6.1 Description 213(1)
6.6.2 Important causes 213(1)
6.6.3 Clinical features 213(1)
6.6.4 Diagnosis 214(1)
6.6.5 Therapy 214(1)
6.6.6 Prognosis 214(1)
7 Pleural Diseases 215(13)
7.1 Pleural Effusion 215(5)
7.1.1 Definition 215(1)
7.1.2 Etiology 215(1)
7.1.3 Transudate or exudate 215(1)
7.1.4 Special instances 216(1)
7.1.5 Clinical manifestations 216(1)
7.1.6 Diagnosis 216(2)
7.1.7 Therapy 218(2)
7.2 Hemothorax 220(1)
7.2.1 Description 220(1)
7.2.2 Etiology 220(1)
7.2.3 Clinical manifestations 220(1)
7.2.4 Diagnosis 220(1)
7.2.5 Therapy 220(1)
7.3 Chylothorax 221(2)
7.3.1 Definition 221(1)
7.3.2 Etiology 221(1)
7.3.3 Clinical manifestations 221(1)
7.3.4 Diagnosis 222(1)
7.3.5 Therapy 222(1)
7.4 Mesothelioma 223(1)
7.4.1 Definition 223(1)
7.4.2 Clinical manifestations 223(1)
7.4.3 Diagnosis 223(1)
7.4.4 Therapy 223(1)
7.4.5 Prognosis 223(1)
7.5 Pneumothorax (PTX) 224(4)
7.5.1 Definition 224(1)
7.5.2 Etiology 224(1)
7.5.3 Clinical manifestations 225(1)
7.5.4 Diagnosis 225(1)
7.5.5 Therapy 225(3)
8 Lung Cancer 228(13)
8.1 Etiology/Risk Factors 228(1)
8.2 Clinical Features 228(2)
8.2.1 Symptoms 229(1)
8.2.2 Paraneoplastic syndromes 230(1)
8.3 Classification 230(6)
8.3.1 Diagnosis and staging 231(1)
8.3.2 Staging of NSCLC 232(4)
8.3.3 Staging for SCLC 236(1)
8.4 Therapy 236(2)
8.5 Follow-Up 238(1)
8.6 Solitary Pulmonary Nodule (SPN) 238(3)
8.6.1 Facts & figures 238(1)
8.6.2 Differential diagnosis 238(2)
8.6.3 Approach to SPN 240(1)
9 Other Lung Diseases 241(11)
9.1 Atelectasis 241(2)
9.1.1 Definition 241(1)
9.1.2 Etiology 241(1)
9.1.3 Clinical manifestations 242(1)
9.1.4 Differential diagnosis 242(1)
9.1.5 Therapy 242(1)
9.2 Hemoptysis 243(2)
9.2.1 Definition 243(1)
9.2.2 Etiology 243(1)
9.2.3 Diagnosis 244(1)
9.2.4 Therapy 244(1)
9.3 Sleep Apnea 245(7)
9.3.1 Definition 245(1)
9.3.2 Prevalence 245(1)
9.3.3 Subgroups 245(1)
9.3.4 Obstructive sleep apnea (OSA) 246(3)
9.3.5 Central sleep apnea (CSA) 249(1)
9.3.6 Sleep-Related Hypoventilation 250(2)
Syndrome
10 Therapy252(55)
10.1 Medical Gas Therapy 252(14)
10.1.1 Oxygen therapy 252(10)
10.1.2 Hyperbaric oxygen therapy 262(2)
10.1.3 Nitric oxide (NO) therapy 264(1)
10.1.4 Heliox therapy 265(1)
10.2 Respiratory Drugs 266(10)
10.2.1 Bronchodilators 266(4)
10.2.2 Inhaled corticosteroids 270(1)
10.2.3 Asthma/COPD combination 270(1)
medications
10.2.4 Leukotrine inhibitors 271(1)
10.2.5 Mucolytics, expectorants 272(1)
10.2.6 Phosphodiesterase 4 (PDE4) 272(1)
inhibitors
10.2.7 Mast cell stabilizers 273(1)
10.2.8 Antitussives 273(2)
10.2.9 Other respiratory drugs 275(1)
10.3 Antimicrobials 276(23)
10.3.1 Organism-Antibiotics 276(1)
10.3.2 Penicillins 277(4)
10.3.3 Cephalosporins 281(7)
10.3.4 Carbapenems 288(1)
10.3.5 Monobactams 288(1)
10.3.6 Glycopeptides 289(1)
10.3.7 Tetracyclines 289(1)
10.3.8 Macrolides, Ketolides 290(2)
10.3.9 Aminoglycosides 292(1)
10.3.10 Lincosamides 293(1)
10.3.11 Chloramphenicol 293(1)
10.3.12 Quinolones 293(3)
10.3.13 Folate antagonists 296(1)
10.3.14 Nitromidazoles 297(1)
10.3.15 Streptogramines 298(1)
10.3.16 Oxazolidinones 298(1)
10.3.17 Cyclic lipopeptides 298(1)
10.3.18 Other antimicrobials 299(1)
10.4 Antimycobacterials 299(2)
10.4.1 Antituberculosis drugs 299(2)
10.5 Antiviral 301(2)
10.5.1 Anti-herpetic drugs 301(1)
10.5.2 Anti-influenza drugs 302(1)
10.5.3 Anti-Respiratory-Syncytial-Virus 302(1)
(Anti-RSV) drugs
10.6 Antifungals 303(4)
10.6.1 Drugs for subcutaneous and 303(3)
systemic mycoses
10.6.2 Drugs for superficial mycoses 306(1)
11 Appendix 307(12)
11.1 Abbreviations 307(9)
11.2 Equations 316(2)
11.3 Conversions 318(1)
12 Index 319